NCT02958176

Brief Summary

Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to increases in HRV as well as improvements in symptoms associated with several psychological disorders, some of which are comorbid with sexual arousal problems in women. Autogenic training also facilitates increases in HRV and was recently associated with acute increases in sexual arousal among sexually healthy women. The primary aim of the current study is to examine the efficacy of HRV biofeedback, with and without autogenic training, for the treatment of female sexual arousal disorder (FSAD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 31, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 8, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

October 11, 2018

Status Verified

October 1, 2018

Enrollment Period

1.3 years

First QC Date

October 31, 2016

Last Update Submit

October 10, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Physiological sexual arousal assessed by vaginal photoplethysmography

    One month

  • Subjective sexual arousal assessed by Film Scale (Heiman & Rowland, 1983)

    One month

  • Sexual function assessed by Female Sexual Function Index (Rosen et al., 2000)

    Two months

Secondary Outcomes (3)

  • Depression symptoms assessed by Beck Depression Inventory-II (Beck, Brown, & Steer, 1996)

    Two months

  • Anxiety symptoms assessed by Beck Anxiety Inventory (Beck et al., 1988)

    Two months

  • Interoceptive awareness assessed by the Multidimensional Assessment of Interoceptive Awareness (Mehling et al., 2012)

    Two months

Study Arms (3)

HRV Biofeedback

EXPERIMENTAL

At home HRV biofeedback using mobile device

Behavioral: HRV Biofeedback

HRV Biofeedback with Autogenic Training

EXPERIMENTAL

At home HRV biofeedback using mobile device plus autogenic training recording

Behavioral: HRV BiofeedbackBehavioral: Autogenic Training

Wait List

NO INTERVENTION

Wait list control

Interventions

HRV BiofeedbackBEHAVIORAL

At-home heart rate variability biofeedback using Elite HRV app and Polar H7 chest strap

HRV BiofeedbackHRV Biofeedback with Autogenic Training

Autogenic training recording provided on a CD

HRV Biofeedback with Autogenic Training

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Premenopausal (18-40 years)
  • Fluent in English
  • Heterosexual or bisexual
  • Score of 26.55 or less on the Female Sexual Function Index (FSFI)
  • Current sexual arousal dysfunction
  • Ownership of an Elite HRV compatible device (recent iPhone, iPad, or Android)

You may not qualify if:

  • Pregnant or breastfeeding
  • History of or current sexually transmitted infections
  • History of major pelvic surgery
  • History of childhood sexual abuse
  • Currently taking androgens, estrogens, or other medical treatments to enhance sexual arousal
  • Current psychosis
  • If on antidepressants or antihypertensives, must be stabilized for at least 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas at Austin

Austin, Texas, 78751, United States

Location

MeSH Terms

Interventions

Autogenic Training

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Cindy M Meston

    The University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2016

First Posted

November 8, 2016

Study Start

October 1, 2016

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

October 11, 2018

Record last verified: 2018-10

Locations